Stage I Triple-Negative Breast Cancer: Melissa's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage I
- Biomarkers
- BRCA mutation reported; triple-negative breast cancer
- Sex
- Female
- Treatment
- surgery, chemotherapy, reconstruction and surveillance
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- High-risk screening used MRI, mammogram, and ultrasound about every 6 months because of BRCA mutation/family history
- A routine mammogram after a recent clean MRI found a tiny left-breast lump/shadow
- Deep needle biopsy confirmed Stage I triple-negative breast cancer
- Bilateral mastectomy with reconstruction/expanders came first, with no lymph-node involvement
- Chemotherapy followed for 12 cycles, including a Red Devil-type treatment; exact regimen was not fully specified
- No recurrence was reported 10 years later.
What happened, in summary
Melissa Berry was 42 when routine high-risk screening found Stage I triple-negative breast cancer. Breast cancer ran strongly on her mother’s side, and Melissa had learned she carried a BRCA mutation. Because of that, she was being followed closely with MRI, mammogram, and ultrasound about every 6 months. She had recently had a clean MRI and expected her mammogram to be routine. Before the mammogram, a clinician felt a tiny lump in the left breast. Initial imaging did not clearly show cancer, but the head of the cancer center saw a shadow and insisted on a deep needle biopsy. That biopsy found a cancerous tumor. Because the tumor appeared quickly, her oncologist suspected triple-negative disease, later confirmed. Melissa had surgery first: a bilateral mastectomy with reconstruction using expanders and later implants. She had no lymph-node involvement, which supported the Stage I diagnosis. Chemotherapy followed; the video description says she completed 12 cycles, and Melissa describes receiving a Red Devil-type chemotherapy, though the exact full regimen is not specified. She focused on taking treatment one step at a time and managing the emotional weight of surgery and chemotherapy. As of July 2023, Melissa was a 10-year triple-negative breast cancer survivor with no recurrence reported, and she was using advocacy work to help others navigate diagnosis and survivorship.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer